Recent News

• 06.03.2025 - 425 - Prospectuses and communications, business combinations
• 06.03.2025 - 8-K - Current report
• 06.03.2025 - Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
• 06.02.2025 - 8-K - Current report
• 05.14.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
• 05.05.2025 - 3 - Initial statement of beneficial ownership of securities
• 05.02.2025 - DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 05.02.2025 - DEF 14A - Definitive proxy statements
• 04.22.2025 - 8-K - Current report
• 04.22.2025 - PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition

Recent Filings

• 06.03.2025 - 8-K Current report
• 06.03.2025 - 425 Prospectuses and communications, business combinations
• 06.03.2025 - EX-99.1 EX-99.1
• 06.02.2025 - 8-K Current report
• 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.05.2025 - 3 Initial statement of beneficial ownership of securities
• 05.02.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 05.02.2025 - DEF 14A Other definitive proxy statements
• 04.22.2025 - 8-K Current report
• 04.22.2025 - EX-99.1 EX-99.1